{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:47:50Z","timestamp":1767116870864,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"EU MSCA-ITN CognitionNet","award":["FP7-PEOPLE-2013-ITN 607508"],"award-info":[{"award-number":["FP7-PEOPLE-2013-ITN 607508"]}]},{"name":"Technology Foundation STW Take-off valorization grant","award":["2015\/1657 4\/STW"],"award-info":[{"award-number":["2015\/1657 4\/STW"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.clinph.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T22:39:05Z","timestamp":1536619145000},"page":"2325-2332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds"],"prefix":"10.1016","volume":"129","author":[{"given":"Sonja","family":"Simpraga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibert D.","family":"Mansvelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert Jan","family":"Groeneveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen P.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon-Shlomo","family":"Poil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Linkenkaer-Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2018.08.014_b0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0269881116681417","article-title":"Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation","volume":"31","author":"Alvarez-Jimenez","year":"2017","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0010","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/bcp.13268","article-title":"An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine","volume":"83","author":"Baakman","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/jama.1977.03280220061024","article-title":"Reversal of central anticholinergic syndrome by galanthamine","volume":"238","author":"Baraka","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.clinph.2018.08.014_b0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-015-0260-0","article-title":"The therapeutic potential of alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia","volume":"29","author":"Beinat","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinph.2018.08.014_b0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0306-4522(00)00071-3","article-title":"Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication","volume":"98","author":"Court","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.clinph.2018.08.014_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02244079","article-title":"Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood","volume":"103","author":"Curran","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinph.2018.08.014_b0035","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2362.1998.00393.x","article-title":"Scopolamine model of dementia: electroencephalogram findings and cognitive performance","volume":"28","author":"Ebert","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clinph.2018.08.014_b0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S1461145705005407","article-title":"Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans","volume":"9","author":"Ellis","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/hup.613","article-title":"Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans","volume":"19","author":"Erskine","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.pbb.2005.04.010","article-title":"Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans","volume":"81","author":"Green","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.clinph.2018.08.014_b0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fphys.2012.00450","article-title":"Detrended fluctuation analysis: a scale-free view on neuronal oscillations","volume":"3","author":"Hardstone","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.clinph.2018.08.014_b0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00401706.1970.10488634","article-title":"Ridge regression: biased estimation for nonorthogonal problems","volume":"12","author":"Hoerl","year":"1970","journal-title":"Technometrics"},{"key":"10.1016\/j.clinph.2018.08.014_b0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: from basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinph.2018.08.014_b0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuropharm.2013.02.015","article-title":"Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans","volume":"84","author":"Jasinska","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinph.2018.08.014_b0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000367889","article-title":"The acetylcholine index: an electroencephalographic marker of cholinergic activity in the living human brain applied to Alzheimer's disease and other dementias","volume":"39","author":"Johannsson","year":"2015","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.clinph.2018.08.014_b0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0166-2236(99)01471-X","article-title":"Nicotinic receptors in the brain: correlating physiology with function","volume":"22","author":"Jones","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.clinph.2018.08.014_b0085","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.clinph.2018.08.014_b0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/(SICI)1099-1077(199711\/12)12:6<573::AID-HUP924>3.0.CO;2-W","article-title":"EEG correlates of acute nicotinic and muscarinic cholinergic blockade: separate and combined administration of mecamylamine and scopolamine in normal human subjects","volume":"12","author":"Knott","year":"1997","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0095","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1073\/pnas.1019676108","article-title":"Neuronal assembly dynamics in the beta1 frequency range permits short-term memory","volume":"108","author":"Kopell","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clinph.2018.08.014_b0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00213-005-0164-7","article-title":"Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization","volume":"184","author":"Levin","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinph.2018.08.014_b0105","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1177\/0269881109105573","article-title":"The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects","volume":"24","author":"Liem-Moolenaar","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0110","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1177\/0269881109106942","article-title":"The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects","volume":"24","author":"Liem-Moolenaar","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0115","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1523\/JNEUROSCI.21-04-01370.2001","article-title":"Long-range temporal correlations and scaling behavior in human brain oscillations","volume":"21","author":"Linkenkaer-Hansen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinph.2018.08.014_b0120","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1073\/pnas.0811699106","article-title":"Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer disease","volume":"106","author":"Montez","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clinph.2018.08.014_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuropharm.2014.10.021","article-title":"The nicotinic cholinergic system function in the human brain","volume":"96","author":"Nees","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinph.2018.08.014_b0130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF02247425","article-title":"Acute nicotinic blockade produces cognitive impairment in normal humans","volume":"108","author":"Newhouse","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinph.2018.08.014_b0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/npp.1994.11","article-title":"Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior","volume":"10","author":"Newhouse","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinph.2018.08.014_b0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","article-title":"Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease","volume":"82","author":"Parri","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1063\/1.166141","article-title":"Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series","volume":"5","author":"Peng","year":"1995","journal-title":"Chaos"},{"key":"10.1016\/j.clinph.2018.08.014_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0091-3057(96)00183-9","article-title":"Effects of mecamylamine on spontaneous EEG and performance in smokers and non-smokers","volume":"56","author":"Pickworth","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.clinph.2018.08.014_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0091-3057(88)90438-8","article-title":"Mecamylamine reduces some EEG effects of nicotine chewing gum in humans","volume":"30","author":"Pickworth","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.clinph.2018.08.014_b0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1460-9568.2011.07748.x","article-title":"Fast network oscillations in vitro exhibit a slow decay of temporal auto-correlations","volume":"34","author":"Poil","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.clinph.2018.08.014_b0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002130050430","article-title":"Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia","volume":"134","author":"Robbins","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinph.2018.08.014_b0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/026988110401800403","article-title":"Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders","volume":"18","author":"Sacco","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinph.2018.08.014_b0175","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1038\/s41598-017-06165-4","article-title":"EEG machine learning for accurate detection of cholinergic intervention and Alzheimer's disease","volume":"7","author":"Simpraga","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinph.2018.08.014_b0180","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.clinph.2010.01.008","article-title":"The use of EEG in Alzheimer's disease, with and without scopolamine \u2013 a pilot study","volume":"121","author":"Snaedal","year":"2010","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2018.08.014_b0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinph.2018.08.014_b0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130000409","article-title":"Effects of the nicotinic antagonist mecamylamine on inspection time","volume":"150","author":"Thompson","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinph.2018.08.014_b0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1467-9868.2011.00771.x","article-title":"Regression shrinkage and selection via the lasso: a retrospective","volume":"73","author":"Tibshirani","year":"2011","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.clinph.2018.08.014_b0200","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s40263-014-0201-3","article-title":"Targeting brain alpha7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status","volume":"28","author":"Valles","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinph.2018.08.014_b0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13195-014-0086-x","article-title":"Eyes-closed task-free electroencephalography in clinical trials for Alzheimer's disease: an emerging method based upon brain dynamics","volume":"6","author":"van Straaten","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.clinph.2018.08.014_b0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10916-008-9218-9","article-title":"Determination of sleep stage separation ability of features extracted from EEG signals using principle component analysis","volume":"34","author":"Vural","year":"2010","journal-title":"J Med Syst"},{"year":"2011","series-title":"Data mining: practical machine learning tools and techniques","author":"Witten","key":"10.1016\/j.clinph.2018.08.014_b0215"},{"key":"10.1016\/j.clinph.2018.08.014_b0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J R Stat Soc Series B Stat Methodol"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245718312008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245718312008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:49:08Z","timestamp":1761392948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245718312008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1388245718312008"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2018.08.014","relation":{},"ISSN":["1388-2457"],"issn-type":[{"type":"print","value":"1388-2457"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}